Access Vascular, a Bedford, MA-based medical device company developing innovative venous access devices that eliminate thrombotic risk, raised $3.7m in funding.
Backers included individual investors and angelMD, an investment platform and marketplace connecting innovative medical startups, physicians, investors and industry partners.
The company intends to use the funds for the submission of a 510(k) application later this year for its lead product.
Leed by James Biggins, founder, president and CEO, Access Vascular is developing the HydroPICC™, a peripherally inserted central catheter that has been shown in lab testing to reduce the accumulation of platelets and in turn, the risk of thrombosis.
Its pipeline includes midlines, dialysis catheter, and ports, all in various stages of development.